Financial Data and Key Metrics Changes - In 2025, the company achieved a core EPS growth of 8% and a core ROE expansion of 30 basis points, reaching a target of 18%+ by 2027 [7][24] - The company generated $6.4 billion in remittances and returned nearly $5.5 billion to shareholders, with a LICAT ratio of 136% and a leverage ratio of 23.9% [7][25] - The adjusted book value per share increased by 6% to CAD 38.27, despite significant capital returns to shareholders [25] Business Line Data and Key Metrics Changes - New business CSM growth exceeded 20% in each insurance segment, contributing to double-digit growth in core earnings [5][15] - Global WAM reported net outflows of $9.5 billion, primarily due to large retirement plan redemptions, but still maintained strong margins and core earnings growth [16][21] - In Asia, APE sales decreased by 3%, but new business CSM and new business value showed strong double-digit growth, with NBV margin expanding by 5.5 percentage points to 41.2% [20][21] Market Data and Key Metrics Changes - The U.S. segment saw a 9% increase in APE sales, with new business CSM growing by 34%, although core earnings decreased by 22% due to lower investment spreads and unfavorable claims experience [22][23] - In Canada, APE sales and new business value increased by 2% and 4% respectively, driven by individual insurance and annuity sales [22] Company Strategy and Development Direction - The company introduced a refreshed enterprise strategy focused on growth and customer choice, with strategic investments in various markets, including a joint venture in India and acquisitions in Indonesia [9][10] - The company aims to become an AI-powered organization, investing in AI to enhance efficiency and customer experience, ranking first among global life insurers for AI maturity [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating macroeconomic and geopolitical uncertainties, emphasizing the diversified nature of the business as a strength [5][6] - The company anticipates continued growth in core earnings and is optimistic about achieving its 2027 targets, despite challenges in specific markets [15][49] Other Important Information - The company announced a 10% increase in its quarterly common share dividend and received approval for a new NCIB program to repurchase up to 42 million shares [7][8] - The company is focused on maintaining a balanced, diversified business model while making strategic investments to strengthen its portfolio [9][10] Q&A Session Summary Question: Clarification on Hong Kong sales and regulatory changes - Management noted that while there was a decline in sales due to regulatory changes, they expect sales to normalize as distributors adjust [28][30] Question: Increase in NBV margin in Hong Kong - The increase in NBV margin was attributed to a shift in sales mix, with higher margins from agency and bank channels compared to the broker channel [34][36] Question: Impact of Comvest acquisition on GWAM earnings - The Comvest acquisition is expected to contribute positively to AUMA and core earnings, with strong customer demand anticipated [37][38] Question: Concerns about mortality experience in the U.S. - Management indicated that recent unfavorable mortality experience is viewed as short-term variability, with improvements expected moving forward [42][44] Question: Achieving 18%+ Core ROE target - Management remains confident in reaching the 18%+ Core ROE target by leveraging share buybacks and optimizing capital allocation [47][49]

Core Insights - F&G Annuities & Life, Inc. reported a significant decline in net earnings for Q2 2025, with net earnings attributable to common shareholders at $35 million, or $0.26 per diluted share, compared to $198 million, or $1.55 per share in Q2 2024 [2][10][22] - Adjusted net earnings for Q2 2025 were $103 million, or $0.77 per share, down from $139 million, or $1.10 per share in the same quarter of the previous year [3][10][26] - The company achieved record assets under management (AUM) before flow reinsurance of $69.2 billion, a 13% increase from $61.4 billion in Q2 2024, driven by strong sales [5][7][11] Financial Performance - Gross sales for Q2 2025 were $4.1 billion, a decrease from $4.4 billion in Q2 2024, with net sales at $2.7 billion compared to $3.4 billion in the prior year [6][9][27] - The investment portfolio remains strong, with 97% of fixed maturities rated investment grade, and credit-related impairments averaging 6 basis points over the past five years [11][12] - Adjusted return on assets (ROA) was 0.71% for Q2 2025, down from 0.98% in Q2 2024, while adjusted return on equity (ROE) excluding AOCI increased to 8.8% from 8.4% year-over-year [6][11][14] Sales and Market Position - Retail channel sales reached over $3.6 billion, a 13% increase from Q2 2024, marking one of the best quarters for indexed annuities and record sales for indexed universal life and multiyear guaranteed annuities [8][11][27] - Institutional market sales were $0.5 billion for pension risk transfer, down from $1.2 billion in Q2 2024, reflecting the opportunistic nature of these sales [9][11] - The company continues to focus on organic growth and returning capital to shareholders, having returned $35 million in capital during Q2 2025 [11][14] Capital and Equity - Total equity attributable to common shareholders, excluding AOCI, was $5.9 billion, or $43.39 per share, reflecting an increase of $0.08 per share during the quarter [14][25] - Book value per common share, excluding AOCI, increased to $43.39 from $42.52 at the end of Q2 2024 [6][14][25] - The company is on track to meet its medium-term targets set during the 2023 Investor Day, with expectations for further improvement in operating efficiency [5][11][14]

Core Viewpoint - F&G Annuities & Life, Inc. reported a significant net loss of $25 million for Q1 2025, contrasting sharply with net earnings of $111 million in Q1 2024, primarily due to unfavorable mark-to-market effects and other items [2][3][12]. Financial Performance - Net loss attributable to common shareholders for Q1 2025 was $25 million, or $0.20 per diluted share, compared to net earnings of $111 million, or $0.88 per share, in Q1 2024 [2][12]. - Adjusted net earnings for Q1 2025 were $91 million, or $0.72 per share, down from $108 million, or $0.86 per share, in Q1 2024 [3][12]. - Total revenues for Q1 2025 were $908 million, a decrease from $1.569 billion in Q1 2024 [26]. Assets Under Management (AUM) - Record AUM before flow reinsurance reached $67.4 billion as of March 31, 2025, a 16% increase from $58.0 billion a year earlier [5][9][7]. - Retained AUM was $54.5 billion, reflecting a 9% increase from $49.8 billion in Q1 2024 [7][9]. Sales Performance - Gross sales for Q1 2025 were $2.9 billion, a decrease of 17% from $3.495 billion in Q1 2024 [8][9]. - Net sales were $2.2 billion, slightly down from $2.3 billion in the same quarter of the previous year [12][9]. Investment Portfolio - The investment portfolio maintained high credit quality, with 96% of fixed maturities rated as investment grade [5][9]. - Credit-related impairments remained low, averaging 6 basis points over the past five years and 2 basis points in Q1 2025 [9]. Capital and Liquidity - Total equity attributable to common shareholders, excluding AOCI, was $5.8 billion, or $43.31 per share, as of March 31, 2025 [14][25]. - The debt-to-capitalization ratio, excluding AOCI, was 26.7%, with a commitment to a long-term target of approximately 25% [16][14]. Strategic Initiatives - The company completed a public offering of 8 million shares of common stock in March 2025, generating nearly $269 million for general corporate purposes [21][9]. - F&G returned $30 million of capital to shareholders through common and preferred dividends in Q1 2025, compared to $26 million in Q1 2024 [16][9].